首页> 外文期刊>Archives of dermatological research. >Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome.
【24h】

Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome.

机译:Sezary综合征中CD4 + CD7 +和CD4 + CD7-T淋巴细胞亚群的基因型,表型和功能分析。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The expansion of CD4+CD7- T cells in the peripheral blood of Sezary syndrome (SS) is well known. It remains unclear whether this population contains the dominant T cell clone. Peripheral blood mononuclear cells (PBMC) of five SS patients were sorted by fluorescence-activated cell sorting into CD4+CD7- and CD4+CD7+ populations. These populations were analysed separately for clonality of the T cell receptor gamma chain (TCR-gamma) by PCR-DGGE. The cytokine profile of both populations was investigated by RT-PCR ELISA for IFN-gamma, IL-2, IL-4, IL-5, IL-10, IL-13 and IL-15. In three other patients with known Vbeta-usage, the dominant T cell clones were phenotypically characterized by double staining. PCR-DGGE of TCR-gamma demonstrated that all patients had a clonal population in their blood and that this population was present in CD4+CD7- and CD4+CD7+ populations. Concerning mRNA cytokine transcription, the two populations did not show any consistent differences. In three patients with identified clones (Vbeta 3.1, 5.3 and 6.7), double staining revealed positivity for CD2, CD3, CD4, CD5, CD45RO and CD7 in a significant proportion (at least 35%). We conclude that the CD4+CD7- population does not represent the dominant T cell clone in patients with SS. An increase in this population of PBMC in SS might account for deviations in the T cell functions of the patients.
机译:塞扎里综合症(SS)外周血中CD4 + CD7-T细胞的扩增是众所周知的。尚不清楚该群体是否包含显性T细胞克隆。通过荧光激活细胞分选,将5名SS患者的外周血单核细胞(PBMC)分选为CD4 + CD7-和CD4 + CD7 +群体。通过PCR-DGGE分别分析这些群体的T细胞受体γ链(TCR-γ)的克隆性。通过RT-PCR ELISA针对IFN-γ,IL-2,IL-4,IL-5,IL-10,IL-13和IL-15调查了两个种群的细胞因子谱。在其他三位已知Vbeta使用情况的患者中,显性T细胞克隆在表型上通过双重染色来表征。 TCR-γ的PCR-DGGE表明,所有患者的血液中都有克隆种群,并且该种群存在于CD4 + CD7-和CD4 + CD7 +种群中。关于mRNA细胞因子的转录,这两个群体没有显示出任何一致的差异。在三例已鉴定出克隆(Vbeta 3.1、5.3和6.7)的患者中,双重染色显示CD2,CD3,CD4,CD5,CD45RO和CD7的阳性率很高(至少35%)。我们得出结论,CD4 + CD7-群体不代表SS患者的显性T细胞克隆。 SS中PBMC数量的增加可能解释了患者T细胞功能的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号